SCI Abstract

search
+
Systematic review and meta-analysis of randomized controlled trials of ketamine in the treatment of refractory anxiety spectrum disorders
Systematic review and meta-analysis of randomized controlled trials of ketamine in the treatment of refractory anxiety spectrum disorders
Background:Anxiety disorders are common, associated with significant burden of disease, and have high levels of treatment ...
Comparison of psychiatric symptoms between patients with major depression with higher and lower levels of high-sensitivity C-reactive protein in the serum: a preliminary study
Comparison of psychiatric symptoms between patients with major depression with higher and lower levels of high-sensitivity C-reactive protein in the serum: a preliminary study
1. Beurel, E, Toups, M, Nemeroff, CB. The bidirectional relationship of depression and inflammation: double trouble. Neuro...
Transcranial magnetic stimulation for post-traumatic stress disorder
Transcranial magnetic stimulation for post-traumatic stress disorder
Post-traumatic stress disorder (PTSD) is a debilitating psychiatric disorder. While current treatment options are effectiv...
MTORC1 signaling as a biomarker in major depressive disorder and its pharmacological modulation by novel rapid-acting antidepressants
MTORC1 signaling as a biomarker in major depressive disorder and its pharmacological modulation by novel rapid-acting antidepressants
Major depressive disorder (MDD) is a multifactorial psychiatric disorder with obscure pathophysiology. A biomarker-based a...
Outcomes in treatment-resistant schizophrenia: symptoms, function and clozapine plasma concentrations
Outcomes in treatment-resistant schizophrenia: symptoms, function and clozapine plasma concentrations
Background:Clozapine is the only medication licenced for treating patients with treatment-refractory schizophrenia. Howeve...
CoMET: a randomised controlled trial of co-commencement of metformin versus placebo as an adjunctive treatment to attenuate weight gain in patients with schizophrenia newly commenced on clozapine
CoMET: a randomised controlled trial of co-commencement of metformin versus placebo as an adjunctive treatment to attenuate weight gain in patients with schizophrenia newly commenced on clozapine
Background:There is limited evidence on interventions to minimise weight gain at clozapine commencement. We compared the e...
Effect of aripiprazole as an adjunct to atypical antipsychotics on weight and metabolic profile: a 12-week open-label trial
Effect of aripiprazole as an adjunct to atypical antipsychotics on weight and metabolic profile: a 12-week open-label trial
Background:Atypical antipsychotics are widely prescribed, yet have been associated with weight gain and metabolic syndrome...
Efficacy and safety of lamotrigine in the treatment of bipolar disorder across the lifespan: a systematic review
Efficacy and safety of lamotrigine in the treatment of bipolar disorder across the lifespan: a systematic review
Background:Bipolar disorder (BD) is a cyclic mood disorder characterised by alternating episodes of mania/hypomania and de...
Repetitive transcranial magnetic stimulation for major depressive disorder: basic principles and future directions
Repetitive transcranial magnetic stimulation for major depressive disorder: basic principles and future directions
Repetitive transcranial magnetic stimulation (rTMS) is a safe and well-tolerated intervention for major depressive disorde...
Clozapine discontinuation withdrawal symptoms in schizophrenia
Clozapine discontinuation withdrawal symptoms in schizophrenia
Clozapine is an atypical antipsychotic used in treatment-resistant schizophrenia. Whilst clozapine is highly effective, th...
Asenapine: an atypical antipsychotic with atypical formulations
Asenapine: an atypical antipsychotic with atypical formulations
Asenapine is a second-generation (atypical) antipsychotic medication not available in a pill that can be swallowed; rather...
Vortioxetine as a new frontier in the treatment of chronic neuropathic pain: a review and update
Vortioxetine as a new frontier in the treatment of chronic neuropathic pain: a review and update
Chronic neuropathic pain (CNP) is a disabling medical condition that impairs the health-related quality-of-life of affecte...
Successful use of tapering strips for hyperbolic reduction of antidepressant dose: a cohort study
Successful use of tapering strips for hyperbolic reduction of antidepressant dose: a cohort study
Background:Tapering strips facilitate antidepressant discontinuation, allowing for personalised titration of discontinuati...
Prophylactic effects or withdrawal reactions? An analysis of time-to-event data from antidepressant relapse prevention trials submitted to the FDA
Prophylactic effects or withdrawal reactions? An analysis of time-to-event data from antidepressant relapse prevention trials submitted to the FDA
Background:Relapse prevention trials build the scientific foundation for recommendation of antidepressant continuation and...
The role of lumateperone in the treatment of schizophrenia
The role of lumateperone in the treatment of schizophrenia
Schizophrenia is a devastating mental disorder resulting in marked morbidity and mortality despite the optimal use of all ...
Possible pharmacogenetic factors in clozapine treatment failure: a case report
Possible pharmacogenetic factors in clozapine treatment failure: a case report
There is still much to learn about the predictors of therapeutic response in psychiatry, but progress is gradually being m...
Cognitive effects of vortioxetine in older adults: a systematic review
Cognitive effects of vortioxetine in older adults: a systematic review
Many older adults experience a deterioration in cognitive function with aging, and this can have a negative impact on qual...
format_indent_increase